The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

pathdoc

Forum Replies Created

Viewing 1 reply thread
  • Replies
      pathdoc
      Participant

      yes, pathologist

      pathdoc
      Participant

      yes, pathologist

      pathdoc
      Participant

      yes, pathologist

      pathdoc
      Participant

      Prognosis is great for early lesions.  But not perfect, very unfortunately so.

      Recent patient who I had signed as In situ melanoma with rare possible single cells of superficial invasion (Stage 0 vs early IA, 2.5 yrs ago).  Received appropriate wide excision with no additional disease seen.  Now with large axillary node.  Initial core biopsy of node for of brown pigment but no tumor cells seen. Excision of node is now recommended for full evaluation as this is still highly suspicious. The patient has had previous melanoma in situ diagnosed else where as well as reported long history of biopsies of several other "atypical melanocytic nevi"…. 

      The absolute predictability of the behavior of these is an impossibility.

      All practioners want to do the right thing for their patients.  I know I personally agonize over this.  I see over 10,000 skin biopsies a year.  Most fortunately are very straight forward.  The opposite challenge of this is over calling melanocytic lesions with not only the potential for morbidity of additional procedure but also as this board is testament too… the anxiety that may come with a Melanoma diagnosis at any stage. (Especially if over called or over staged.)

      Melanomas don't read text books or journal articles or survival curves.

      I give all of you who carry this diagnosis, my hopes and prayers for the best possible outcomes.

       

      pathdoc
      Participant

      Prognosis is great for early lesions.  But not perfect, very unfortunately so.

      Recent patient who I had signed as In situ melanoma with rare possible single cells of superficial invasion (Stage 0 vs early IA, 2.5 yrs ago).  Received appropriate wide excision with no additional disease seen.  Now with large axillary node.  Initial core biopsy of node for of brown pigment but no tumor cells seen. Excision of node is now recommended for full evaluation as this is still highly suspicious. The patient has had previous melanoma in situ diagnosed else where as well as reported long history of biopsies of several other "atypical melanocytic nevi"…. 

      The absolute predictability of the behavior of these is an impossibility.

      All practioners want to do the right thing for their patients.  I know I personally agonize over this.  I see over 10,000 skin biopsies a year.  Most fortunately are very straight forward.  The opposite challenge of this is over calling melanocytic lesions with not only the potential for morbidity of additional procedure but also as this board is testament too… the anxiety that may come with a Melanoma diagnosis at any stage. (Especially if over called or over staged.)

      Melanomas don't read text books or journal articles or survival curves.

      I give all of you who carry this diagnosis, my hopes and prayers for the best possible outcomes.

       

      pathdoc
      Participant

      Prognosis is great for early lesions.  But not perfect, very unfortunately so.

      Recent patient who I had signed as In situ melanoma with rare possible single cells of superficial invasion (Stage 0 vs early IA, 2.5 yrs ago).  Received appropriate wide excision with no additional disease seen.  Now with large axillary node.  Initial core biopsy of node for of brown pigment but no tumor cells seen. Excision of node is now recommended for full evaluation as this is still highly suspicious. The patient has had previous melanoma in situ diagnosed else where as well as reported long history of biopsies of several other "atypical melanocytic nevi"…. 

      The absolute predictability of the behavior of these is an impossibility.

      All practioners want to do the right thing for their patients.  I know I personally agonize over this.  I see over 10,000 skin biopsies a year.  Most fortunately are very straight forward.  The opposite challenge of this is over calling melanocytic lesions with not only the potential for morbidity of additional procedure but also as this board is testament too… the anxiety that may come with a Melanoma diagnosis at any stage. (Especially if over called or over staged.)

      Melanomas don't read text books or journal articles or survival curves.

      I give all of you who carry this diagnosis, my hopes and prayers for the best possible outcomes.

       

Viewing 1 reply thread
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.